Dr Mark Noble

Dr Mark Noble is a Consultant Clinical Oncologist who delivers comprehensive care for patients diagnosed with cancer. With a unique professional background, he initially trained and qualified as a General Practitioner before transitioning into clinical oncology. This dual training provides him with a broad medical perspective, allowing him to adopt a holistic and patient-centred approach to cancer management. Dr Noble specialises in managing complex oncological cases, focusing on providing tailored treatment plans that align with each patient's individual needs and preferences.

In his clinical practice, Dr Noble focuses on the management of lung, brain, and skin malignancies using advanced therapeutic modalities. His expertise encompasses both precise radiotherapy techniques and modern systemic anti-cancer therapies. He is experienced in utilising sophisticated radiotherapeutic approaches, including stereotactic ablative radiotherapy (SABR) and MR Linac technology, which enable precise targeting of tumours while minimising the impact on surrounding healthy tissues. Additionally, he oversees systemic treatments such as targeted therapies and immunotherapy, as well as specialised radiotherapeutic options like superficial x-ray and electron beam therapies for skin lesions.

Dr Noble completed his medical studies at the University of Southampton, graduating with his medical degree in 2007. In addition to his clinical responsibilities, he plays an active role in medical education and clinical research. He serves as a Clinical Lead responsible for training and mentoring junior doctors specialising in clinical oncology, and he actively leads clinical trials aimed at improving treatment outcomes and advancing novel oncological therapies.